SCHERING/ORION FARESTON ANTI-ESTROGEN FOR TREATMENT OF METASTATIC BREAST CANCER "SIMILAR" TO TAMOXIFEN, FDA ONCOLOGIC COMMITTEE SAYS IN APPROVAL VOTE
Executive Summary
Orion-Farmos' Fareston is "similar" to tamoxifen for advanced breast cancer in postmenopausal women, according to a consensus reached by FDA's Oncologic Drugs Advisory Committee Oct. 16.